US Stock MarketDetailed Quotes

HOLX Hologic

Watchlist
  • 63.240
  • -0.380-0.60%
Close Feb 14 16:00 ET
  • 63.240
  • 0.0000.00%
Post 20:01 ET
14.19BMarket Cap20.01P/E (TTM)

About Hologic Company

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Company Profile

SymbolHOLX
Company NameHologic
Listing DateMar 2, 1990
Issue Price14.00
Founded1985
CEOMr. Stephen P. Macmillan
MarketNASDAQ
Employees7063
Fiscal Year Ends09-27
Address250 Campus Drive
CityMarlborough
ProvinceMassachusetts
CountryUnited States of America
Zip Code01752
Phone1-508-263-2900

Company Executives

  • Name
  • Position
  • Salary
  • Stephen P. Macmillan
  • Chairman of the Board, Chief Executive Officer and President
  • 15.82M
  • Essex D. Mitchell
  • Chief Operating Officer
  • 4.08M
  • Karleen M. Oberton
  • Chief Financial Officer
  • 4.09M
  • Benjamin J. Cohn
  • Vice President, Corporate Controller and Principal Accounting Officer
  • --
  • Diana De Walt
  • Senior Vice President, Human Resources
  • --
  • Mark Horvath
  • Division President, Breast and Skeletal Health Solutions
  • --
  • Jennifer Schneiders
  • President, Diagnostics Solutions
  • --
  • Brandon Schnittker
  • Division President, GYN Surgical Solutions
  • --
  • Jan Verstreken
  • Group President, International
  • 3.59M
  • Dr. Martin D. Madaus,PhD
  • Director
  • --
  • Charles J. Dockendorff
  • Independent Director
  • 354.95K
  • Amy A. Wendell
  • Lead Independent Director
  • 357.45K
  • Christiana Stamoulis, M.B.A.
  • Independent Director
  • 329.95K
  • Stacey D. Stewart
  • Independent Director
  • 329.95K
  • Nanaz Mohtashami
  • Independent Director
  • 329.95K
  • Sally Wellinghoff Crawford
  • Independent Director
  • 357.45K
  • Scott T. Garrett
  • Independent Director
  • 349.95K
  • Dr. Ludwig N. Hantson, PhD
  • Independent Director
  • 329.95K
  • John M. Griffin
  • General Counsel
  • 3.47M

Trending Stocks

Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More